Inventor · disambiguated record
Eilyn Lacy
Also filed as: LACY EILYN · LACY EILYN R
5 granted patents·5 pending applications·4 citations·filing 2009–2024
71Inventor score
Files withJANSSEN BIOTECH INC4CUNNINGHAM MARK2JANSSEN PHARMACEUTICA NV2BRIGHAM-BURKE MICHAEL1JANNSEN BIOTECH INC1
Top patents by PatentIndex Score
10 records- 0184US11414484B2Anti-CCL17 antibodiesJANSSEN BIOTECH INC·Filed 2020·Granted Aug 16, 2022·1 cites·12 claims
- 0279US9944697B2Anti-CCL17 antibodiesJANSSEN BIOTECH INC·Filed 2014·Granted Apr 17, 2018·1 cites·8 claims
- 0376US10829549B2Anti-CCL17 antibodiesJANNSEN BIOTECH INC·Filed 2017·Granted Nov 10, 2020·1 cites·7 claims
- 0476US10633435B2Anti-PHF-tau antibodies and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Apr 28, 2020·1 cites·19 claims
- 0575US2022348647A1Anti-ccl17 antibodiesJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 0661US12234280B2Anti-PHF-tau antibodies and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Feb 25, 2025·0 cites·10 claims
- 0761US2025163182A1Enpp3 and cd3 binding agents and methods of use thereofJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 0849US2014017250A1Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular DiseasesCUNNINGHAM MARK·Filed 2013·Application pending·0 cites
- 0944US2009298186A1Method to Assess Stability of ProteinsBRIGHAM-BURKE MICHAEL·Filed 2009·Application pending·0 cites
- 1041US2013090457A1Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular DiseasesCUNNINGHAM MARK·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →